{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T10:35:37Z","timestamp":1726223737232},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1007\/s00347-006-1368-x","type":"journal-article","created":{"date-parts":[[2006,5,31]],"date-time":"2006-05-31T14:11:34Z","timestamp":1149084694000},"page":"621-643","source":"Crossref","is-referenced-by-count":3,"title":["Multiple Sklerose"],"prefix":"10.1007","volume":"103","author":[{"given":"T.","family":"Ziemssen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Wilhelm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Ziemssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"1368_CR1","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1001\/archopht.1991.01080120057025","volume":"109","author":"Optic","year":"1991","unstructured":"Optic Neuritis Study Group (1991) The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Arch Ophthalmol 109(12): 1673\u20131678","journal-title":"Arch Ophthalmol"},{"key":"1368_CR2","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/jnnp.57.8.897","volume":"57","author":"Andersson","year":"1994","unstructured":"Andersson M, Alvarez-Cermeno J, Bernardi G et al. (1994) Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatry 57(8): 897\u2013902","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1368_CR3","doi-asserted-by":"crossref","unstructured":"Armstrong RA (1999) Multiple sclerosis and the eye. Ophthalmic Physiol Opt 19 [Suppl 2]: S32\u2013S42","DOI":"10.1016\/S0275-5408(98)00069-6"},{"key":"1368_CR4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0161-6420(84)34296-8","volume":"91","author":"Arnold","year":"1984","unstructured":"Arnold AC, Pepose JS, Hepler RS, Foos RY (1984) Retinal periphlebitis and retinitis in multiple sclerosis. I. Pathologic characteristics. Ophthalmology 91(3): 255\u2013262","journal-title":"Ophthalmology"},{"key":"1368_CR5","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11940-999-0034-4","volume":"1","author":"Averbuch-Heller","year":"1999","unstructured":"Averbuch-Heller L (1999) Acquried nystagmus. Curr Treat Options Neurol 1: 68\u201373","journal-title":"Curr Treat Options Neurol"},{"key":"1368_CR6","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1093\/brain\/120.11.2059","volume":"120","author":"Barkhof","year":"1997","unstructured":"Barkhof F, Filippi M, Miller DH et al. (1997) Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 120 (Pt 11): 2059\u20132069","journal-title":"Brain"},{"key":"1368_CR7","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/archopht.1995.01100020014004","volume":"113","author":"Beck","year":"1995","unstructured":"Beck RW (1995) The optic neuritis treatment trial: three-year follow-up results. Arch Ophthalmol 113(2): 136\u2013137","journal-title":"Arch Ophthalmol"},{"key":"1368_CR8","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/ana.410420523","volume":"42","author":"Beck","year":"1997","unstructured":"Beck RW (1997) Clinically definite multiple sclerosis following optic neuritis. Ann Neurol 42(5): 815\u2013816","journal-title":"Ann Neurol"},{"key":"1368_CR9","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/archneur.1993.00540080050013","volume":"50","author":"Beck","year":"1993","unstructured":"Beck RW, Arrington J, Murtagh FR et al. (1993) Brain magnetic resonance imaging in acute optic neuritis. Experience of the Optic Neuritis Study Group. Arch Neurol 50(8): 841\u2013846","journal-title":"Arch Neurol"},{"key":"1368_CR10","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/archopht.1993.01090060061023","volume":"111","author":"Beck","year":"1993","unstructured":"Beck RW, Cleary PA (1993) Optic neuritis treatment trial. One-year follow-up results. Arch Ophthalmol 111(6): 773\u2013775","journal-title":"Arch Ophthalmol"},{"key":"1368_CR11","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0161-6420(94)31103-1","volume":"101","author":"Beck","year":"1994","unstructured":"Beck RW, Cleary PA, Backlund JC (1994) The course of visual recovery after optic neuritis. Experience of the Optic Neuritis Treatment Trial. Ophthalmology 101(11): 1771\u20131778","journal-title":"Ophthalmology"},{"key":"1368_CR12","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1056\/NEJM199312093292403","volume":"329","author":"Beck","year":"1993","unstructured":"Beck RW, Cleary PA, Trobe J et al. (1993) The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group. N Engl J Med 329(24): 1764\u20131769","journal-title":"N Engl J Med"},{"key":"1368_CR13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ajo.2004.01.040","volume":"137","author":"Beck","year":"2004","unstructured":"Beck RW, Gal RL, Bhatti MT et al. (2004) Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial. Am J Ophthalmol 137(1): 77\u201383","journal-title":"Am J Ophthalmol"},{"key":"1368_CR14","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1001\/archopht.121.2.292","volume":"121","author":"Beck","year":"2003","unstructured":"Beck RW, Trobe JD, Moke PS et al. (2003) High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial. Arch Ophthalmol 121(7): 944\u2013949","journal-title":"Arch Ophthalmol"},{"key":"1368_CR15","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMoa011341","volume":"346","author":"Brex","year":"2002","unstructured":"Brex PA, Ciccarelli O, O\u2019Riordan JI et al. (2002) A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med 346(3): 158\u2013164","journal-title":"N Engl J Med"},{"key":"1368_CR16","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/jnnp.70.3.390","volume":"70","author":"Brex","year":"2001","unstructured":"Brex PA, Miszkiel KA, O\u2019Riordan JI et al. (2001) Assessing the risk of early multiple sclerosis in patients with clinically isolated syndromes: the role of a follow up MRI. J Neurol Neurosurg Psychiatry 70(3): 390\u2013393","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1368_CR17","first-page":"226","volume":"99","author":"Chin","year":"1995","unstructured":"Chin S, Suzuki Y, Ohashi T, Kase M (1995) Long-term prolongation of direct pupillary light reflex latency and P100 latency of pattern visual evoked potential in unilateral optic neuritis. Nippon Ganka Gakkai Zasshi 99(2): 226\u2013231","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"1368_CR18","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/S0140-6736(00)04725-5","volume":"357","author":"Comi","year":"2001","unstructured":"Comi G, Filippi M, Barkhof F et al. (2001) Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study. Lancet 357(9268): 1576\u20131582","journal-title":"Lancet"},{"key":"1368_CR19","first-page":"13","volume":"49","author":"Comi","year":"1999","unstructured":"Comi G, Leocani L, Medaglini S et al. (1999) Evoked potentials in diagnosis and monitoring of multiple sclerosis. Electroencephalogr Clin Neurophysiol Suppl 49: 13\u201318","journal-title":"Electroencephalogr Clin Neurophysiol Suppl"},{"key":"1368_CR20","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJM200011163432001","volume":"343","author":"Confavreux","year":"2000","unstructured":"Confavreux C, Vukusic S, Moreau T, Adeleine P (2000) Relapses and progression of disability in multiple sclerosis. N Engl J Med 343(20): 1430\u20131438","journal-title":"N Engl J Med"},{"key":"1368_CR21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archneur.58.1.65","volume":"58","author":"De Stefano","year":"2001","unstructured":"De Stefano N, Narayanan S, Francis GS et al. (2001) Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch Neurol 58(1): 65\u201370","journal-title":"Arch Neurol"},{"key":"1368_CR22","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/S0161-6420(96)30429-6","volume":"103","author":"Dunker","year":"1996","unstructured":"Dunker S, Wiegand W (1996) Prognostic value of magnetic resonance imaging in monosymptomatic optic neuritis. Ophthalmology 103(11): 1768\u20131773","journal-title":"Ophthalmology"},{"key":"1368_CR23","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1056\/NEJM198612253152603","volume":"315","author":"Ebers","year":"1986","unstructured":"Ebers GC, Bulman DE, Sadovnick AD et al. (1986) A population-based study of multiple sclerosis in twins. N Engl J Med 315(26): 1638\u20131642","journal-title":"N Engl J Med"},{"key":"1368_CR24","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/377150a0","volume":"377","author":"Ebers","year":"1995","unstructured":"Ebers GC, Sadovnick AD, Risch NJ (1995) A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group. Nature 377(6545): 150\u2013151","journal-title":"Nature"},{"key":"1368_CR25","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/S0161-6420(03)00477-9","volume":"110","author":"Fazzone","year":"2003","unstructured":"Fazzone HE, Lefton DR, Kupersmith MJ (2003) Optic neuritis: correlation of pain and magnetic resonance imaging. Ophthalmology 110(8): 1646\u20131649","journal-title":"Ophthalmology"},{"key":"1368_CR26","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0161-6420(87)33349-4","volume":"94","author":"Fleishman","year":"1987","unstructured":"Fleishman JA, Beck RW, Linares OA, Klein JW (1987) Deficits in visual function after resolution of optic neuritis. Ophthalmology 94(8): 1029\u20131035","journal-title":"Ophthalmology"},{"key":"1368_CR27","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1212\/WNL.51.4.1236-b","volume":"51","author":"Francis","year":"1998","unstructured":"Francis G (1998) The 5-year risk of MS after optic neuritis. Neurology 51(4): 1236\u20131238","journal-title":"Neurology"},{"key":"1368_CR28","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S1474-4422(05)00992-0","volume":"4","author":"Frohman","year":"2005","unstructured":"Frohman EM, Frohman TC, Zee DS et al. (2005) The neuro-ophthalmology of multiple sclerosis. Lancet Neurol 4: 111\u2013121","journal-title":"Lancet Neurol"},{"key":"1368_CR29","first-page":"79","volume":"2","author":"Frohman","year":"1996","unstructured":"Frohman EM, Solomon D, Zee DS (1996) Nuclear, supranuclear and internuclear eye movement abnormalities in MS. Int MS J 2: 79\u201389","journal-title":"Int MS J"},{"key":"1368_CR30","doi-asserted-by":"crossref","unstructured":"Ghezzi A, Martinelli V, Rodegher M et al. (2000) The prognosis of idiopathic optic neuritis. Neurol Sci 21 [4 Suppl 2]: S865\u2013S869","DOI":"10.1007\/s100720070028"},{"key":"1368_CR31","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s001150170057","volume":"72","author":"Grauer","year":"2001","unstructured":"Grauer O, Offenhausser M, Schmidt J et al. (2001) Glucocorticosteroid therapy in optic neuritis and multiple sclerosis. Evidence from clinical studies and practical recommendations. Nervenarzt 72(8): 577\u2013589","journal-title":"Nervenarzt"},{"key":"1368_CR32","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1136\/jnnp.45.5.431","volume":"45","author":"Gresty","year":"1982","unstructured":"Gresty MA, Eli JJ, Findley LJ (1982) Acqired pendular nystagmus: its characteristics, localizing value and pathophysiology. J Neurol Neurosurg Psychiatry 45: 431\u2013439","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1368_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-510X(94)00248-M","volume":"129","author":"Guthrie","year":"1995","unstructured":"Guthrie TC, Nelson DA (1995) Influence of temperature changes on multiple sclerosis: critical review of mechanisms and research potential. J Neurol Sci 129(1): 1\u20138","journal-title":"J Neurol Sci"},{"key":"1368_CR34","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jns.2005.01.003","volume":"231","author":"Heckmann","year":"2005","unstructured":"Heckmann JM, Lambson FM, Little F, Owen EP (2005) Thiopurine methyltransferase (TPMT) heterozygosity and enzyme activity as predictive tests for the development of azathoprine-related adverse events. J Neurol Sci 231(1): 71\u201380","journal-title":"J Neurol Sci"},{"key":"1368_CR35","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1136\/jnnp.49.10.1125","volume":"49","author":"Hely","year":"1986","unstructured":"Hely MA, McManis PG, Doran TJ et al. (1986) Acute optic neuritis: a prospective study of risk factors for multiple sclerosis. J Neurol Neurosurg Psychiatry 49(10): 1125\u20131130","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1368_CR36","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1136\/jnnp.74.8.1139","volume":"74","author":"Hickman","year":"2003","unstructured":"Hickman SJ, Kapoor R, Jones SJ et al. (2003) Corticosteroids do not prevent optic nerve atrophy following optic neuritis. J Neurol Neurosurg Psychiatry 74(8): 1139\u20131141","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1368_CR37","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJM200009283431301","volume":"343","author":"Jacobs","year":"2000","unstructured":"Jacobs LD, Beck RW, Simon JH et al. (2000) Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. N Engl J Med 343(13): 898\u2013904","journal-title":"N Engl J Med"},{"key":"1368_CR38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/(SICI)1097-4679(199901)55:1<21::AID-JCLP2>3.0.CO;2-B","volume":"55","author":"Jean","year":"1999","unstructured":"Jean VM, Paul RH, Beatty WW (1999) Psychological and neuropsychological predictors of coping patterns by patients with multiple sclerosis. J Clin Psychol 55(1): 21\u201326","journal-title":"J Clin Psychol"},{"key":"1368_CR39","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1001\/archopht.1994.01090190094027","volume":"112","author":"Keltner","year":"1994","unstructured":"Keltner JL, Johnson CA, Spurr JO, Beck RW (1994) Visual field profile of optic neuritis. One-year follow-up in the Optic Neuritis Treatment Trial. Arch Ophthalmol 112(7): 946\u2013953","journal-title":"Arch Ophthalmol"},{"key":"1368_CR40","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0002-9394(99)00304-9","volume":"128","author":"Keltner","year":"1999","unstructured":"Keltner JL, Johnson CA, Spurr JO, Beck RW (1999) Comparison of central and peripheral visual field properties in the optic neuritis treatment trial. Am J Ophthalmol 128(5): 543\u2013553","journal-title":"Am J Ophthalmol"},{"key":"1368_CR41","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s003470170169","volume":"98","author":"Kiefer","year":"2001","unstructured":"Kiefer G, Rieckmann P (2001) Optic neuritis. First manifestation of multiple sclerosis? Current diagnostic and therapeutic strategies. Ophthalmologe 98(3): 310\u2013318","journal-title":"Ophthalmologe"},{"key":"1368_CR42","doi-asserted-by":"crossref","unstructured":"Lauer K (1997) Ecologic studies of multiple sclerosis. Neurology 49 [2 Suppl 2]: S18\u2013S26","DOI":"10.1212\/WNL.49.2_Suppl_2.S18"},{"key":"1368_CR43","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/brain\/110.2.405","volume":"110","author":"Lightman","year":"1987","unstructured":"Lightman S, McDonald WI, Bird AC et al. (1987) Retinal venous sheathing in optic neuritis. Its significance for the pathogenesis of multiple sclerosis. Brain 110 (Pt 2): 405\u2013414","journal-title":"Brain"},{"key":"1368_CR44","unstructured":"Littig E, Schmidt RM, Neumann V (2002) Differentialdiagnose, Sonderformen und Diagnosesicherung. In: Schmidt RM, Hoffmann F (Hrsg) Multiple Sklerose. Urban und Fischer, M\u00fcnchen, S 71\u2013100"},{"key":"1368_CR45","unstructured":"Matthews WB, Compston A, Allen IV, Martyn CN (1991) McAlpine\u2019s multiple sclerosis, 2nd edn. Churchill Livingstone, London"},{"key":"1368_CR46","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","volume":"50","author":"McDonald","year":"2001","unstructured":"McDonald WI, Compston A, Edan G et al. (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50(1): 121\u2013127","journal-title":"Ann Neurol"},{"key":"1368_CR47","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1191\/1352458502ms767xx","volume":"8","author":"McFarland","year":"2002","unstructured":"McFarland HF, Barkhof F, Antel J, Miller DH (2002) The role of MRI as a surrogate outcome measure in multiple sclerosis. Mult Scler 8(1): 40\u201351","journal-title":"Mult Scler"},{"key":"1368_CR48","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1191\/0269215503cr618oa","volume":"17","author":"McKeown","year":"2003","unstructured":"McKeown LP, Porter-Armstrong AP, Baxter GD (2003) The needs and experiences of caregivers of individuals with multiple sclerosis: a systematic review. Clin Rehabil 17(3): 234\u2013248","journal-title":"Clin Rehabil"},{"key":"1368_CR49","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/jnnp.55.6.450","volume":"55","author":"Miller","year":"1992","unstructured":"Miller DH, Thompson AJ, Morrissey SP et al. (1992) High dose steroids in acute relapses of multiple sclerosis: MRI evidence for a possible mechanism of therapeutic effect. J Neurol Neurosurg Psychiatry 55(6): 450\u2013453","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1368_CR50","unstructured":"Multiple Sklerose Therapie Konsensus Gruppe (2004) Symptomatische Therapie der Multiplen Sklerose. Nervenarzt 75 [Suppl 1]: 2\u201339"},{"key":"1368_CR51","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1177\/135245859800400502","volume":"4","author":"O\u2019Riordan","year":"1998","unstructured":"O\u2019Riordan JI, Gawne CM, Coles A et al. (1998) T1 hypointense lesion load in secondary progressive multiple sclerosis: a comparison of pre versus post contrast loads and of manual versus semi automated threshold techniques for lesion segmentation. Mult Scler 4(5): 408\u2013412","journal-title":"Mult Scler"},{"key":"1368_CR52","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/brain\/121.3.495","volume":"121","author":"O\u2019Riordan","year":"1998","unstructured":"O\u2019Riordan JI, Thompson AJ, Kingsley DP et al. (1998) The prognostic value of brain MRI in clinically isolated syndromes of the CNS. Brain 121: 495\u2013503","journal-title":"Brain"},{"key":"1368_CR53","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0165-5728(00)00444-6","volume":"113","author":"Oksenberg","year":"2001","unstructured":"Oksenberg JR, Baranzini SE, Barcellos LF, Hauser SL (2001) Multiple sclerosis: genomic rewards. J Neuroimmunol 113(2): 171\u2013184","journal-title":"J Neuroimmunol"},{"key":"1368_CR54","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ana.410130302","volume":"13","author":"Poser","year":"1983","unstructured":"Poser CM, Paty DW, Scheinberg L et al. (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13(3): 227\u2013231","journal-title":"Ann Neurol"},{"key":"1368_CR55","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1177\/135245850100700512","volume":"7","author":"Ramsaransing","year":"2001","unstructured":"Ramsaransing G, Maurits N, Zwanikken C, De Keyser J (2001) Early prediction of a benign course of multiple sclerosis on clinical grounds: a systematic review. Mult Scler 7(5): 345\u2013347","journal-title":"Mult Scler"},{"key":"1368_CR56","first-page":"implications","volume":"sclerosis","author":"Richards","year":"2002","unstructured":"Richards RG, Sampson FC, Beard SM, Tappenden PA (2002) A review of the natural history and epidemiology of multiple sclerosis: implications for recourse allocation and health economic models. Health Technol Assess 6(10)","journal-title":"A review of the natural history and epidemiology of multiple"},{"key":"1368_CR57","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1212\/WNL.38.2.185","volume":"38","author":"Rizzo","year":"1988","unstructured":"Rizzo JF, Lessell S (1988) Risk of developing multiple sclerosis after uncomplicated optic neuritis: a long-term prospective study. Neurology 38(2): 185\u2013190","journal-title":"Neurology"},{"key":"1368_CR58","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1212\/WNL.45.2.244","volume":"45","author":"Rodriguez","year":"1995","unstructured":"Rodriguez M, Siva A, Cross SA et al. (1995) Optic neuritis: a population-based study in Olmsted County, Minnesota. Neurology 45(2): 244\u2013250","journal-title":"Neurology"},{"key":"1368_CR59","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1034\/j.1399-0004.1999.560204.x","volume":"56","author":"Sadovnick","year":"1999","unstructured":"Sadovnick AD, Dircks A, Ebers GC (1999) Genetic counselling in multiple sclerosis: risks to sibs and children of affected individuals. Clin Genet 56(2): 118\u2013122","journal-title":"Clin Genet"},{"key":"1368_CR60","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/ana.410270406","volume":"27","author":"Sandberg-Wollheim","year":"1990","unstructured":"Sandberg-Wollheim M, Bynke H, Cronqvist S et al. (1990) A long-term prospective study of optic neuritis: evaluation of risk factors. Ann Neurol 27(4): 386\u2013393","journal-title":"Ann Neurol"},{"key":"1368_CR61","first-page":"2278","volume":"38","author":"Schneck","year":"1997","unstructured":"Schneck ME, Haegerstrom-Portnoy G (1997) Color vision defect type and spatial vision in the optic neuritis treatment trial. Invest Ophthalmol Vis Sci 38(11): 2278\u20132289","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1368_CR62","first-page":"6625","volume":"161","author":"Sellebjerg","year":"1999","unstructured":"Sellebjerg F, Frederiksen JL, Nielsen PM, Olesen J (1999) Randomized controlled trial of high-dose peroral methylprednisolone in attacks of multiple sclerosis. Ugeskr Laeger 161(48): 6625\u20136629","journal-title":"Ugeskr Laeger"},{"key":"1368_CR63","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1212\/WNL.52.7.1479","volume":"52","author":"Sellebjerg","year":"1999","unstructured":"Sellebjerg F, Nielsen HS, Frederiksen JL, Olesen J (1999) A randomized, controlled trial of oral high-dose methylprednisolone in acute optic neuritis. Neurology 52(7): 1479\u20131484","journal-title":"Neurology"},{"key":"1368_CR64","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/archneur.1988.00520280091021","volume":"45","author":"Sencer","year":"1988","unstructured":"Sencer W (1988) Suspicion of multiple sclerosis. To tell or not to tell? Arch Neurol 45(4): 441\u2013442","journal-title":"Arch Neurol"},{"key":"1368_CR65","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0140-6736(85)92801-6","volume":"1","author":"Sibley","year":"1985","unstructured":"Sibley WA, Bamford CR, Clark K (1985) Clinical viral infections and multiple sclerosis. Lancet 1(8441): 1313\u20131315","journal-title":"Lancet"},{"key":"1368_CR66","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0039-6257(91)90209-X","volume":"36","author":"Slamovits","year":"1991","unstructured":"Slamovits TL, Macklin R, Beck RW et al. (1991) What to tell the patient with optic neuritis about multiple sclerosis. Surv Ophthalmol 36(1): 47\u201350","journal-title":"Surv Ophthalmol"},{"key":"1368_CR67","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/ana.410330511","volume":"33","author":"Smith","year":"1993","unstructured":"Smith ME, Stone LA, Albert PS et al. (1993) Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions. Ann Neurol 33(5): 480\u2013489","journal-title":"Ann Neurol"},{"key":"1368_CR68","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1034\/j.1600-0420.2001.790302.x","volume":"79","author":"Soderstrom","year":"2001","unstructured":"Soderstrom M (2001) Optic neuritis and multiple sclerosis. Acta Ophthalmol Scand 79(3): 223\u2013227","journal-title":"Acta Ophthalmol Scand"},{"key":"1368_CR69","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1212\/WNL.50.3.708","volume":"50","author":"Soderstrom","year":"1998","unstructured":"Soderstrom M, Ya-Ping J, Hillert J, Link H (1998) Optic neuritis: prognosis for multiple sclerosis from MRI, CSF, and HLA findings. Neurology 50(3): 708\u2013714","journal-title":"Neurology"},{"key":"1368_CR70","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1034\/j.1600-0420.2000.078004407.x","volume":"78","author":"Takasoh","year":"2000","unstructured":"Takasoh M, Mizota A, Adachi-Usami E (2000) Comparative studies on pattern VECP between patients with ischemic optic neuropathy and optic neuritis. Acta Ophthalmol Scand 78(4): 407\u2013410","journal-title":"Acta Ophthalmol Scand"},{"key":"1368_CR71","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1136\/jnnp.63.5.682","volume":"63","author":"Thomke","year":"1997","unstructured":"Thomke F, Lensch E, Ringel K, Hopf HC (1997) Isolated cranial nerve palsies in multiple sclerosis. J Neurol Neurosurg Psychiatry 63(5): 682\u2013685","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1368_CR72","first-page":"702","volume":"21","author":"Tintore","year":"2000","unstructured":"Tintore M, Rovira A, Martinez MJ et al. (2000) Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. AJNR Am J Neuroradiol 21(4): 702\u2013706","journal-title":"AJNR Am J Neuroradiol"},{"key":"1368_CR73","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1442-9071.2000.00270.x","volume":"28","author":"Towler","year":"2000","unstructured":"Towler HM, Lightman S (2000) Symptomatic intraocular inflammation in multiple sclerosis. Clin Experiment Ophthalmol 28(2): 97\u2013102","journal-title":"Clin Experiment Ophthalmol"},{"key":"1368_CR74","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0002-9394(14)75429-7","volume":"121","author":"Trobe","year":"1996","unstructured":"Trobe JD, Beck RW, Moke PS, Cleary PA (1996) Contrast sensitivity and other vision tests in the optic neuritis treatment trial. Am J Ophthalmol 121(5): 547\u2013553","journal-title":"Am J Ophthalmol"},{"key":"1368_CR75","unstructured":"Warner J, Lessell S (1994) Neuro-ophthalmology of multiple sclerosis. Clin Neurosci 2(3\u20134): 180\u2013188"},{"key":"1368_CR76","doi-asserted-by":"crossref","unstructured":"Weinshenker BG (1994) Natural history of multiple sclerosis. Ann Neurol 36 [Suppl]: S6\u201311","DOI":"10.1002\/ana.410360704"},{"key":"1368_CR77","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/brain\/112.1.133","volume":"112","author":"Weinshenker","year":"1989","unstructured":"Weinshenker BG, Bass B, Rice GP et al. (1989) The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain 112 (Pt 1): 133\u2013146","journal-title":"Brain"},{"key":"1368_CR78","first-page":"211","volume":"208","author":"Zee","year":"1983","unstructured":"Zee DS (1983) Nystagmus in multiple sclerosis. Bull Soc Belge Ophtalmol 208 (Pt 1): 211\u2013217","journal-title":"Bull Soc Belge Ophtalmol"},{"key":"1368_CR79","doi-asserted-by":"crossref","unstructured":"Ziemssen T (2005) Modulating processes within the central nervous system is central to therapeutic control of multiple sclerosis. J Neurol 252 [Suppl 5]: v38\u2013v45","DOI":"10.1007\/s00415-005-5007-2"},{"key":"1368_CR80","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.autrev.2005.03.005","volume":"4","author":"Ziemssen","year":"2005","unstructured":"Ziemssen T, Ziemssen F (2005) The role of the humoral immune system in multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE). Autoimmun Rev 4(7): 460\u2013467","journal-title":"Autoimmun Rev"},{"key":"1368_CR81","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jns.2005.03.006","volume":"233","author":"Zivadinov","year":"2005","unstructured":"Zivadinov R (2005) Steroids and brain atrophy in multiple sclerosis. J Neurol Sci 233(1): 73\u201381","journal-title":"J Neurol Sci"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-006-1368-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-006-1368-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-006-1368-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T09:50:43Z","timestamp":1559037043000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-006-1368-x"}},"subtitle":["Ein Update mit praktischen Regeln f\u00fcr die ophthalmologische Praxis"],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":81,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["1368"],"URL":"https:\/\/doi.org\/10.1007\/s00347-006-1368-x","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}